Literature DB >> 32524098

Engraftment Syndrome and Acute Graft-versus-Host Disease: A Meta-Analysis.

Kittika Poonsombudlert1, Jakrin Kewcharoen1, Chattip Prueksapraopong2, Nath Limpruttidham1.   

Abstract

Engraftment syndrome (ES) has been associated with the surge of neutrophils and cytokines, which is similar to the presumed underlying pathophysiology behind acute graft-versus-host disease (aGVHD). However, there has been no meta-analysis to evaluate the association; therefore, the team attempted to verify an association between ES and aGVHD through meta-analysis. The team searched for titles of articles in MEDLINE (PubMed), the Cochrane Library, and the EMBASE database up until December 2018 that evaluated the association between ES and aGVHD and conducted a random effect meta-analysis of 8 studies involving a total of 1,945 participants to report the pooled odds ratio (OR) for association of ES and aGVHD. The team found a significantly increased odds of developing aGVHD in patients with ES with the pooled OR of 2.76 (95% confidence interval [CI]: 1.64-4.63) and an I2 = 64.5%. In conclusion, patients with ES have significantly higher odds of developing aGVHD compared to patients without ES. ©Copyright 2020 by University Health Partners of Hawai‘i (UHP Hawai‘i).

Entities:  

Keywords:  acute graft-versus-host disease; auto-aggression syndrome; capillary leakage syndrome; engraftment syndrome; meta-analysis

Mesh:

Year:  2020        PMID: 32524098      PMCID: PMC7281341     

Source DB:  PubMed          Journal:  Hawaii J Health Soc Welf        ISSN: 2641-5216


  31 in total

Review 1.  Engraftment syndrome following hematopoietic stem cell transplantation.

Authors:  T R Spitzer
Journal:  Bone Marrow Transplant       Date:  2001-05       Impact factor: 5.483

Review 2.  Prevention of graft-vs.-host disease.

Authors:  Andrew R Rezvani; Rainer F Storb
Journal:  Expert Opin Pharmacother       Date:  2012-07-07       Impact factor: 3.889

Review 3.  History of graft-versus-host disease.

Authors:  Huib M Vriesendorp; Peter J Heidt
Journal:  Exp Hematol       Date:  2016-05-26       Impact factor: 3.084

4.  Procalcitonin and cytokine profiles in engraftment syndrome in pediatric stem cell transplantation.

Authors:  Nirali N Shah; Theresa M Watson; Bonnie Yates; David J Liewehr; Seth M Steinberg; David Jacobsohn; Terry J Fry
Journal:  Pediatr Blood Cancer       Date:  2016-10-20       Impact factor: 3.167

5.  Enhanced human hematopoietic stem and progenitor cell engraftment by blocking donor T cell-mediated TNFα signaling.

Authors:  Weijia Wang; Hisaki Fujii; Hye Jin Kim; Karin Hermans; Tatiana Usenko; Stephanie Xie; Zhi-Juan Luo; Jennifer Ma; Cristina Lo Celso; John E Dick; Timm Schroeder; Joerg Krueger; Donna Wall; R Maarten Egeler; Peter W Zandstra
Journal:  Sci Transl Med       Date:  2017-12-20       Impact factor: 17.956

6.  Hyperacute GVHD: risk factors, outcomes, and clinical implications.

Authors:  Rima M Saliba; Marcos de Lima; Sergio Giralt; Borje Andersson; Issa F Khouri; Chitra Hosing; Shubhra Ghosh; Joyce Neumann; Yvonne Hsu; Jorge De Jesus; Muzaffar H Qazilbash; Richard E Champlin; Daniel R Couriel
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

7.  Marrow engraftment and clinical manifestations of capillary leak syndrome.

Authors:  R A Cahill; T R Spitzer; A Mazumder
Journal:  Bone Marrow Transplant       Date:  1996-07       Impact factor: 5.483

8.  Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes.

Authors:  Lawrence Chang; David Frame; Thomas Braun; Erin Gatza; David A Hanauer; Shuang Zhao; John M Magenau; Kathryn Schultz; Hemasri Tokala; James L M Ferrara; John E Levine; Pavan Reddy; Sophie Paczesny; Sung Won Choi
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-02       Impact factor: 5.742

Review 9.  Pre-engraftment syndrome: clinical significance and pathophysiology.

Authors:  Young-Ho Lee; Wee-Jin Rah
Journal:  Blood Res       Date:  2016-09-23

10.  Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments.

Authors:  Carson Ka-Lok Lo; Dominik Mertz; Mark Loeb
Journal:  BMC Med Res Methodol       Date:  2014-04-01       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.